Kronos Bio Inc (KRON)
1.02
-0.01
(-0.97%)
USD |
NASDAQ |
May 03, 16:00
1.01
-0.01
(-0.98%)
After-Hours: 20:00
Kronos Bio Price to Book Value: 0.3853 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.3853 |
| May 02, 2024 | 0.3891 |
| May 01, 2024 | 0.3891 |
| April 30, 2024 | 0.3891 |
| April 29, 2024 | 0.3778 |
| April 26, 2024 | 0.3778 |
| April 25, 2024 | 0.3702 |
| April 24, 2024 | 0.3627 |
| April 23, 2024 | 0.3589 |
| April 22, 2024 | 0.3627 |
| April 19, 2024 | 0.3815 |
| April 18, 2024 | 0.3891 |
| April 17, 2024 | 0.3929 |
| April 16, 2024 | 0.4118 |
| April 15, 2024 | 0.4307 |
| April 12, 2024 | 0.4269 |
| April 11, 2024 | 0.4269 |
| April 10, 2024 | 0.4231 |
| April 09, 2024 | 0.4269 |
| April 08, 2024 | 0.4533 |
| April 05, 2024 | 0.4647 |
| April 04, 2024 | 0.4533 |
| April 03, 2024 | 0.476 |
| April 02, 2024 | 0.4798 |
| April 01, 2024 | 0.5213 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.4911 |
| March 27, 2024 | 0.4684 |
| March 26, 2024 | 0.4495 |
| March 25, 2024 | 0.4647 |
| March 22, 2024 | 0.4798 |
| March 21, 2024 | 0.4533 |
| March 20, 2024 | 0.4571 |
| March 19, 2024 | 0.4382 |
| March 18, 2024 | 0.4344 |
| March 15, 2024 | 0.4382 |
| March 14, 2024 | 0.4307 |
| March 13, 2024 | 0.4317 |
| March 12, 2024 | 0.4169 |
| March 11, 2024 | 0.4595 |
| March 08, 2024 | 0.478 |
| March 07, 2024 | 0.478 |
| March 06, 2024 | 0.4447 |
| March 05, 2024 | 0.378 |
| March 04, 2024 | 0.3928 |
| March 01, 2024 | 0.378 |
| February 29, 2024 | 0.3854 |
| February 28, 2024 | 0.4558 |
| February 27, 2024 | 0.4706 |
| February 26, 2024 | 0.4224 |
| February 23, 2024 | 0.3965 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2449
Minimum
Nov 14 2023
3.773
Maximum
Jan 22 2021
1.306
Average
0.672
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.955 |
| AIM ImmunoTech Inc | 2.116 |
| IGC Pharma Inc | 3.599 |
| NovaBay Pharmaceuticals Inc | 2.094 |
| Protalix BioTherapeutics Inc | 2.481 |
Price to Book Value Related Metrics
| PS Ratio | 9.366 |
| Price | 1.02 |
| Earnings Yield | -191.2% |
| Market Cap | 61.30M |